Molecular Mechanisms of Temporal Lobe Epilepsy

Temporal lobe epilepsy (TLE) arises from a constellation of molecular and cellular alterations in hippocampal and adjacent temporal cortex structures. Dysregulation of excitatory and inhibitory neurotransmission underpins the generation and propagation of spontaneous seizures, with aberrant expression of ion channels, neurotransmitter receptors and synaptic scaffolding proteins. Intracellular signalling cascades, notably mTOR, MAPK and NF-κB pathways, coordinate neuronal plasticity, neurogenesis and apoptotic processes, contributing to epileptogenesis and seizure-induced neuronal damage. Glial cells, particularly astrocytes and microglia, engage in maladaptive responses, driving neuroinflammation, extracellular matrix remodelling and blood–brain barrier disruption. Epigenetic modifications and non-coding RNAs further refine gene networks that regulate excitability, synaptic strength and cellular resilience. Together, these molecular mechanisms converge to sculpt hyperexcitable circuits, offering targets for therapeutic intervention and biomarker development.

Research from Nature Portfolio

Recent studies have delineated cell-type-specific transcriptomic alterations in TLE. Single-nucleus analysis of human temporal cortex tissue has revealed that distinct populations of principal neurons and GABAergic interneurons exhibit coordinated upregulation of glutamate receptor subunits and auxiliary proteins, while other subtypes remain relatively preserved. These findings underscore the circuit-level specificity of molecular changes driving hyperexcitability. In parallel, a systems-level computational framework has been employed to integrate gene regulatory networks with causal reasoning, leading to the identification of colony-stimulating factor 1 receptor as a candidate therapeutic target. Pharmacological blockade of this receptor has demonstrated efficacy in attenuating seizure frequency in preclinical models, exemplifying the translation of network biology into drug discovery.

Molecular Mechanisms of Temporal Lobe Epilepsy publication trend

The graph below shows the total number of articles in molecular mechanisms of temporal lobe epilepsy across all publications each year (not limited to Nature Index journals).

Technical terms

Excitotoxicity: cell damage due to excessive activation of excitatory neurotransmitter receptors.

Neuroinflammation: inflammatory processes within the central nervous system involving glial activation and cytokine release.

MicroRNA: small non-coding RNA molecules that regulate gene expression post-transcriptionally.

Single-nucleus transcriptomics: sequencing method profiling RNA transcripts from individual cell nuclei to distinguish cell types.

Senescence: irreversible cell cycle arrest with characteristic molecular markers and altered secretory profile.

References

1. Identification of epilepsy-associated neuronal subtypes and gene expression underlying epileptogenesis. Nature Communications (2020).
2. A systems-level framework for drug discovery identifies Csf1R as an anti-epileptic drug target. Nature Communications (2018).
3. Compartment-specific small non-coding RNA changes and nucleolar defects in human mesial temporal lobe epilepsy. Acta Neuropathologica (2024).
4. Astrocyte-derived SerpinA3N promotes neuroinflammation and epileptic seizures by activating the NF-κB signaling pathway in mice with temporal lobe epilepsy. Journal of Neuroinflammation (2023).
5. Comparative Proteomic Profiling of Blood Plasma Revealed Marker Proteins Involved in Temporal Lobe Epilepsy. International Journal of Molecular Sciences (2024).